In today’s fast-paced stock market, understanding the subtle cues of technical analysis is crucial for smart investing.
In this article, we focus on NIO Inc (SGX: NIO) and Frasers Centrepoint Trust (FCT) (SGX: J69U) for displaying bullish indicators.
Key highlights from the technical reports:
NIO
Market Position: NIO broke out of the falling wedge and entered a consolidative range, now showing strong bullish pressure, leading to a ‘technical buy’ position.
Entry Prices and Support Levels: Recommended entry points are at US$4.86, US$4.50, and US$4.10, with established support levels at US$4.54 and US$4.11.
Stop Loss and Resistance Levels: To safeguard investments, a stop loss is advised at US$2.98. The identified resistance levels are at US$5.32 and US$7.00.
Target Prices: Set at US$6.60, US$7.08, US$8.10, and US$9.80.
Company Overview: NIO manufactures and sells automobiles. The company offers electric vehicles and parts, as well as providing battery charging services.
For a more detailed analysis, click on the link to access the report.
Frasers Centrepoint Trust
Market Position: FCT’s strong bullish breakout from the falling wedge is showing strong signs of a bullish reversal, suggesting a ‘technical buy’ position.
Entry Prices and Support Levels: Recommended entry points are at S$2.13, S$2.08, and S$2.03, with established support levels at S$2.10 and S$2.05.
Stop Loss and Resistance Levels: To safeguard investments, a stop loss is advised at S$2.01. Identified resistance levels are at S$2.17 and S$2.32.
Target Prices: Set at S$2.26, S$2.38, S$2.50, and S$2.70.
Company Overview: FCT is a Singapore-domiciled retail real estate investment trust, with a portfolio comprising high-quality suburban retail malls and an office building.
For a more detailed analysis, click on the link to access the report.
Take advantage of the stock’s momentum.
Our goal is to provide you with clear, actionable insights from the complex world of stock charts and trends. Whether you’re an experienced investor or new to the market, our analysis is tailored to help you navigate the market with confidence.
Please refer to the attached report for the disclaimer.
